Cancer-A silent killer: An overview
Yadav Akshay R.*, Mohite Shrinivas K.
Department of Pharmaceutical Chemistry, Rajarambapu College of Pharmacy, Kasegaon, Sangli, Maharashtra, India-415404
*Corresponding Author E-mail: email@example.com
Online published on 16 September, 2020.
Cancer can be characterized as a disease where an uncontrollably growing group of abnormal cells disregarding the normal mechanism of cell division. The healthy cells that are continuously subject to stimuli that determine whether the cell will reproduce, differentiate or die. Cancer cells experience a degree of autonomy from these signals, resulting in uncontrolled growth and proliferation and metastasis. There are over 200 different cancer forms. The sequence, predicting a dominant autosomal gene that resulted in an increased risk of developing breast cancer, was published the same year as the cloned BRCA1 gene. Different model has used cancer and steroid hormone evidence to determine the risk of breast cancer in women with family history of cancer of the breast. There are over sixty different organs in the body that can develop cancer from nearly any cell type in the body. As a result, more than 150 ongoing clinical trials are being conducted that investigate the efficacy of nanotechnological drug carrires which target cancer have developed quickly into the nanotechnology field.
Cancer, Metastasis, Breast cancer, Nanotechnology, Drug carrires.